Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | CTSK | P43235 | 4/20 | 0.32 |
| ▸ | ACHE | P22303 | 1/20 | 0.32 |
| ▸ | BACE1 | P56817 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 2/20 | 0.31 |
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 2/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | FDPS | P14324 | 1/20 | 0.31 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.31 |
| ▸ | SMPD1 | P17405 | 3/20 | 0.31 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.31 |
| ▸ | DDAH1 | O94760 | 1/20 | 0.31 |
| ▸ | GAPDH | P04406 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9255651 | 0.94 | SMPD1 (0.37) | SMPD1TRPA1DDAH1GAPDHMAPT | |
| SCHEMBL9255641 | 0.94 | SMPD1 (0.37) | SMPD1TRPA1DDAH1GAPDHMAPT | |
| SCHEMBL1475751 | 0.86 | — | — | |
| SCHEMBL1475755 | 0.86 | — | — | |
| SCHEMBL1155677 | 0.83 | — | — | |
| SCHEMBL3693302 | 0.79 | LMNA (0.31) | ALDH1A1TSHR | |
| SCHEMBL9255676 | 0.77 | — | — | |
| SCHEMBL6062120 | 0.77 | — | — | |
| SCHEMBL6836188 | 0.77 | — | — | |
| SCHEMBL6062104 | 0.77 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10695272-B2 | Compositions containing microcapsules coated with deposition proteins | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 2020-06-30 | — | — | US | disclosed |
| US-20180250204-A1 | COMPOSITIONS CONTAINING MICROCAPSULES COATED WITH DEPOSITION PROTEINS | INTERNATIONAL FLAVORS & FRAGRANCES INC. | 2018-09-06 | — | — | US | disclosed |
| US-9974720-B2 | Compositions containing microcapsules coated with deposition proteins | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 2018-05-22 | — | — | US | disclosed |
| US-20170189283-A1 | COMPOSITIONS CONTAINING MICROCAPSULES COATED WITH DEPOSITION PROTEINS | INTERNATIONAL FLAVORS AND FRAGRANCES INC. | 2017-07-06 | — | — | US | disclosed |
| EP-2471559-A2 | Antiviral method | Gojo Industries, Inc. (US) | 2012-07-04 | — | — | EP | disclosed |
| EP-2012838-A2 | ANTIVIRAL DISINFECTANTS AND APPLICATIONS | Gojo Industries, Inc. (US) | 2009-01-14 | — | — | EP | disclosed |
| WO-2007095008-A2 | ANTIVIRAL DISINFECTANTS AND APPLICATIONS | GOJO INDUSTRIES, INC. (US) | 2007-08-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10695272-B2 | Compositions containing microcapsules coated with deposition proteins | SAAL1, AUP1, FABP5 | ALDH1A1 4547/4885CTSK 2304/4885ACHE 3050/4885 |
| US-20180250204-A1 | COMPOSITIONS CONTAINING MICROCAPSULES COATED WITH DEPOSITION PROTEINS | SAAL1, AUP1, FABP5 | ALDH1A1 4547/4885CTSK 2304/4885ACHE 3050/4885 |
| US-20170189283-A1 | COMPOSITIONS CONTAINING MICROCAPSULES COATED WITH DEPOSITION PROTEINS | SAAL1, AUP1, FABP5 | ALDH1A1 4547/4885CTSK 2304/4885ACHE 3050/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.